Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,438,125
+$90,760 QoQ
Shares Held
17,475
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1,700
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COZAD ASSET MANAGEMENT INC holds $35,468,302 across 7 Drug Manufacturers - General names. JNJ ranks #2 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
23,746 | $28,481,667 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
17,475 | $4,438,125 | |
| 3 | PFE |
Pfizer Inc
|
35,997 | $866,807 | |
| 4 | AMGN |
Amgen Inc
|
1,667 | $603,654 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,012 | $506,876 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,019 | $346,814 | |
| 7 | NVO |
Novo Nordisk A S
|
4,680 | $224,359 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,438,125 | 17,475 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,347,365 | 17,785 | Shares | Sole | 2026-05-28 | |
| 2025-12-31 | $3,686,814 | 17,815 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,309,932 | 17,851 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,746,597 | 17,981 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,949,298 | 17,784 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,389,122 | 16,520 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,127,685 | 13,129 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,090,380 | 14,302 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,291,540 | 14,486 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,286,209 | 14,586 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,322,388 | 14,911 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $2,471,875 | 14,934 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,314,770 | 14,934 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $2,773,581 | 15,701 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,341,928 | 14,336 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,566,794 | 14,460 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,423,443 | 13,674 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,066,183 | 12,078 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,950,597 | 12,078 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,066,333 | 12,543 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,142,466 | 13,036 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,889,819 | 12,008 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,794,450 | 12,053 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,685,872 | 11,988 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,565,036 | 11,935 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||